HAVE YOU TAKEN UBRELVY (UBROGEPANT)?
The Empress Pregnancy Registry was established for women who have taken Ubrelvy (ubrogepant) or other medication to treat migraines anytime during pregnancy. The goal of this registry is to learn about the health of these women and their babies. Those who have not taken Ubrelvy (ubrogepant) but are pregnant and have clinically diagnosed migraines are also invited to join. Sharing your experience could help others with migraines during pregnancy.
Fill Out the Form Below to Apply
Pregnant women are often excluded from medical trials, so in order to gather information about the effects of certain medications on pregnancy, participants are needed to share their experiences after medication exposure.
What Will I Have to Do?
Fill Out Our Form
To see if you are a good fit, fill out the pre-screener form above to apply. If you qualify, someone from the team will be in touch to go over further details.
speak to the team
A registry team member will contact you to provide additional information, answer any questions you may have and complete the registration process.
Once registration is complete, you can begin answering surveys about your health currently, and in the following months through pregnancy and delivery.
Frequently asked questions
The Empress Pregnancy Registry has been set up to collect information from pregnant women who have taken Ubrelvy (ubrogepant) during pregnancy, and/or who have clinically diagnosed migraines. By sharing your experience, you could help doctors to better understand if Ubrelvy (ubrogepant) has any effect on pregnancy, delivery, or the baby.
If you join this registry, your involvement will last for the duration of your pregnancy and until your baby is at least 12 months old. You can expect to have study check ins once per trimester, and three times after giving birth up to 52 weeks.
Your participation in this registry is voluntary; you may withdraw your consent at any time.
Although it is a good idea to notify your healthcare provider about your participation in the registry, their permission is not required. As part of your agreement to be in the study, you will give your and your baby’s healthcare providers permission to share information about you and your baby.